Novo Nordisk Inc Drug Patent Portfolio

Novo Nordisk Inc's Family Patents


Family Patents



Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Novo Nordisk Inc News

As Patents Expire, Production Costs for Weight-Loss Medications May Drop to $3 Monthly - Science Alert

09 Mar, 2026

Novo Nordisk Stock Experiences Increased Strain Following Profit Alert and Pricing Changes

09 Mar, 2026

Novo and Hims Resolve Legal Dispute and Collaborate on Obesity Medications - Whalesbook

07 Mar, 2026

Could This New Obesity Medication Rescue Novo Nordisk? - AOL.com

07 Mar, 2026

See More